Literature DB >> 22826444

Relevance of immobility and importance of risk assessment management for medically ill patients.

Russell D Hull1.   

Abstract

Recent or continued immobility is a significant risk factor for venous thromboembolism (VTE) in acutely ill medical patients. Patients may benefit from thromboprophylaxis; however, its optimal duration remains unclear. The Extended Clinical Prophylaxis in Acutely Ill Medical Patients (EXCLAIM) study was the first trial to systematically investigate how the degree of immobilization relates to the risk of developing VTE. EXCLAIM offers insights into the duration of VTE risk associated with reduced mobility and helps identify which patients would benefit most from extended-duration thromboprophylaxis. Further recent studies suggest that extended-duration thromboprophylaxis may be in order in certain high-risk patients to protect the patients from the risk of VTE events occurring, particularly in the posthospitalization period. Baseline d-dimer data and level of mobility could be included in risk assessment. Physicians are recommended to consider the use of extended-duration thromboprophylaxis based on individual risk assessment management (RAM) and balance of benefit and harm.

Entities:  

Keywords:  EXCLAIM; immobility; medical patients; thromboprophylaxis; venous thromboembolism

Mesh:

Year:  2012        PMID: 22826444     DOI: 10.1177/1076029612452781

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

1.  Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.

Authors:  Stefania Frasson; Gualberto Gussoni; Pierpaolo Di Micco; Raquel Barba; Laurent Bertoletti; Manuel J Nuñez; Beatriz Valero; Angel Luis Samperiz; Agustina Rivas; Manuel Monreal
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

2.  Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study.

Authors:  Damien Choffat; Pauline Darbellay Farhoumand; Evrim Jaccard; Roxane de la Harpe; Vanessa Kraege; Malik Benmachiche; Christel Gerber; Salomé Leuzinger; Clara Podmore; Minh Khoa Truong; Céline Dumans-Louis; Christophe Marti; Jean-Luc Reny; Drahomir Aujesky; Damiana Rakovic; Andreas Limacher; Jean-Benoît Rossel; Christine Baumgartner; Marie Méan
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

Review 3.  New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients.

Authors:  Kira MacDougall; Alex C Spyropoulos
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241

4.  New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial.

Authors:  Félix Rinfret; Chu-Shu Gu; Suresh Vedantham; Susan R Kahn
Journal:  Res Pract Thromb Haemost       Date:  2022-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.